IBER
Ibere Pharmaceuticals
IBER
IBER
Delisted
IBER was delisted on the 1st of March, 2023.
48 hedge funds and large institutions have $120M invested in Ibere Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 13 increasing their positions, 2 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
Holders
48
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$7.08M | |
| 2 | +$5.71M | |
| 3 | +$5.38M | |
| 4 |
CM
Cohanzick Management
Pleasantville,
New York
|
+$3.45M |
| 5 |
SCM
Saba Capital Management
New York
|
+$2.47M |
Top Sellers
| 1 | -$11.1M | |
| 2 | -$3.94M | |
| 3 | -$1.67M | |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$1.47M |
| 5 |
SCM
Shaolin Capital Management
Miami,
Florida
|
-$1.34M |